Janus Kinase (JAK) Inhibitors Market – Targeted Therapy Transforming Autoimmune Disease Management
Market Overview The Janus kinase (JAK) inhibitors market continues to expand as targeted oral therapies increasingly replace or complement biologic injectables across rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and atopic dermatitis management. JAK inhibitors offer patients the convenience of oral dosing alongside rapid onset of action, reshaping treatment algorithms...
0 Σχόλια 0 Μοιράστηκε 99 Views 0 Προεπισκόπηση